Clinical trial · Observational
Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
NCT07251946CI-TRIAL-00098017completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This retrospective study included 316 bladder cancer patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- overall survival
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. pathological diagnosis of bladder cancer, 2. available clinical information, 3. age \>18 years, 4. patients underwent non-contrast and enhanced abdominal CT examination within 4 weeks before cystectomy for bladder cancer. Exclusion Criteria: 1. other malignancies in combination, 2. less than one month of follow-up or lack of follow-up, 3. patients with T4b stage,distant metastases (M1 stage) 4. image artefacts or poor quality of image alignment.
References
Publications (0)
Data not yet available
No reference posted for this study.